Description

4H-1,4-Benzoxazine-4-Acetamide,n-Cyclopropyl-2-Ethyl-2,3-Dihydro-6-Methyl-3-Oxo-n-(3-Pyridinylmethyl)-(9Ci) is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel active pharmaceutical ingredients (APIs). This compound is critical for research and development in medicinal chemistry, offering a complex heterocyclic scaffold for creating targeted therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new drug candidates, particularly in areas requiring sophisticated molecular architectures.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates targeting central nervous system (CNS) disorders, inflammation, or infectious diseases.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes within R&D laboratories.
• Active Pharmaceutical Ingredient (API) Development: Serves as a precursor in the multi-step synthesis of complex, high-value APIs.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for exploring new synthetic methodologies and heterocyclic chemistry.
• Bioconjugation & Probe Development: Potential use in creating chemical probes or conjugates for biochemical and diagnostic applications due to its functionalized structure.

Basic Information

Product Name	4H-1,4-Benzoxazine-4-Acetamide,n-Cyclopropyl-2-Ethyl-2,3-Dihydro-6-Methyl-3-Oxo-n-(3-Pyridinylmethyl)-(9Ci)
CAS No.	606120-64-3
Molecular Formula	C22H25N3O3
Molecular Weight	379.46 g/mol
Synonyms	N-Cyclopropyl-2-ethyl-2,3-dihydro-6-methyl-3-oxo-N-(pyridin-3-ylmethyl)-4H-1,4-benzoxazine-4-acetamide; 4H-1,4-Benzoxazine-4-acetamide, N-cyclopropyl-2-ethyl-2,3-dihydro-6-methyl-3-oxo-N-(3-pyridinylmethyl)-; 606120-64-3; Benzoxazine acetamide derivative; UNII-7Q5F6S8Q7R; 7Q5F6S8Q7R; SCHEMBL2184221
EINECS	Contact for details

Quality Control

Our 4H-1,4-Benzoxazine-4-Acetamide derivative is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing batch-specific results are provided and can be tailored to meet specific client or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to minimize exposure to atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.